BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Biotech Bay

  Gilead Sciences, Inc. Battles To Shift Debate Over $1,000 Hepatitis Pills From Costs To Cures

  August 5, 2014

   · 

  1 min read
• Business

  Asuragen, Inc. Names Matthew McManus, M.D., Ph.D., President And CEO

  August 5, 2014

   · 

  3 min read
• Drug Development

  Ampio Pharmaceuticals, Inc. Updates On Positive One-Month Results From Ampion Open Label Study

  August 5, 2014

   · 

  3 min read
• Drug Development

  Synthetic Biologics, Inc. On Track To Initiate Clinical Program For SYN-004 To Protect Against C. difficile

  August 5, 2014

   · 

  5 min read
• Business

  Menlo Park’s TesoRx Locks In $10 Million, Secures Key Patent And Taps Renowned Urologist As Chief Medical Officer

  August 5, 2014

   · 

  4 min read
• Drug Development

  Hope Builds For New Novartis AG Heart Failure Drug LCZ696

  August 5, 2014

   · 

  1 min read
• Deals

  Oxford Immunotec Limited Grabs Boulder Diagnostics Assets For $7.9 Million

  August 5, 2014

   · 

  4 min read
• Business

  Medtronic, Inc. Opens Hemodialysis Plant In Chengdu, China

  August 5, 2014

   · 

  1 min read
• FDA

  FDA Green Lights The SynCardia Systems, Inc. Total Artificial Heart With SynHall Valves

  August 5, 2014

   · 

  2 min read
• BioForest

  Already-Rich Juno Therapeutics Reels In Another $134 Million, Has Raised $300 Million In Less Than 12 Months

  August 5, 2014

   · 

  2 min read